ONYX PHARMACEUTICALS INC
DelistedCIK 1012140fmd_04FPQAK8ZAHCA4ZGPV4AWYV09FManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2008 to Jun 30, 2013, 18 periods
Latest annual · FY2012
Millions- Total revenues
- 362
- Gross profit
- 361
- Operating income
- (267)
- Net income
- (188)
- Free cash flow
- (242)
Latest quarter · Q2 FY2013
Millions- Total revenues
- 153
- Gross profit
- 151
- Operating income
- (48)
- Net income
- (53)
- Free cash flow
- (8)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +12.9%
ONYX PHARMACEUTICALS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $362.2 million | $447.2 million | -19% | 10-K 2013-02-28 · proof |
| Gross profit | $360.8 million | 10-K 2013-02-28 · proof | ||
| Operating income | -$267.1 million | $98.3 million | -371.7% | 10-K 2013-02-28 · proof |
| Net income | -$187.8 million | $76.1 million | -346.7% | 10-K 2013-02-28 · proof |
| Cash from operating activities | -$230.5 million | $50.5 million | -556% | 10-K 2013-02-28 · proof |
| Free cash flow | -$241.9 million | $35.4 million | -782.5% | 10-K 2013-02-28 · proof |
| Total assets | $1.4 billion | $1.4 billion | -4.3% | 10-K 2013-02-28 · proof |
| Total liabilities | $531.5 million | $588.3 million | -9.7% | 10-K 2013-02-28 · proof |
| Cash and cash equivalents | $153.2 million | $171.6 million | -10.7% | 10-K 2013-02-28 · proof |
- What was ONYX PHARMACEUTICALS INC's revenue in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported revenue of $362.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $447.2 million the year before (-19%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What was ONYX PHARMACEUTICALS INC's gross profit in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported gross profit of $360.8 million for fiscal 2012 (the year ended Dec 31, 2012). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What was ONYX PHARMACEUTICALS INC's operating income in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported operating income of -$267.1 million for fiscal 2012 (the year ended Dec 31, 2012), against $98.3 million the year before (-371.7%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What was ONYX PHARMACEUTICALS INC's net income in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported net income of -$187.8 million for fiscal 2012 (the year ended Dec 31, 2012), against $76.1 million the year before (-346.7%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What was ONYX PHARMACEUTICALS INC's cash from operating activities in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported cash from operating activities of -$230.5 million for fiscal 2012 (the year ended Dec 31, 2012), against $50.5 million the year before (-556%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What was ONYX PHARMACEUTICALS INC's free cash flow in fiscal 2012?
- ONYX PHARMACEUTICALS INC reported free cash flow of -$241.9 million for fiscal 2012 (the year ended Dec 31, 2012), against $35.4 million the year before (-782.5%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What are ONYX PHARMACEUTICALS INC's total assets?
- As of Dec 31, 2012, ONYX PHARMACEUTICALS INC reported total assets of $1.4 billion, against $1.4 billion a year earlier (-4.3%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What are ONYX PHARMACEUTICALS INC's total liabilities?
- As of Dec 31, 2012, ONYX PHARMACEUTICALS INC reported total liabilities of $531.5 million, against $588.3 million a year earlier (-9.7%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
- What are ONYX PHARMACEUTICALS INC's cash and cash equivalents?
- As of Dec 31, 2012, ONYX PHARMACEUTICALS INC reported cash and cash equivalents of $153.2 million, against $171.6 million a year earlier (-10.7%). Source: the 10-K filed with the SEC on Feb 28, 2013. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1012140&period_type=annual&limit=5"Information only, not investment advice.